Kostas A. Papavassiliou

Artificial Intelligence as a Catalyst for Novel Therapeutic Opportunities in Precision Oncology

Artificial intelligence (AI) is reshaping molecular oncology by making complex biological data tractable and by extending the reach of precision drug discovery. Its emerging value is particularly evident at the interface of immunoengineering and targeted therapy, where computatio...